Evidence map›Paper›PMID 35538059›Full record

ArticleCell death discovery2022

Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice.

Meiling Yan, Yun Li, Qingmao Luo, Wenru Zeng, Xiaoqi Shao, Lun Li, Qing Wang, Dongwei Wang, Yue Zhang, Hongtao Diao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 230 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. cGAS: bridging immunity and metabolic regulation.Journal of molecular cell biology · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Meiling Yan *The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Yun Li *The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Qingmao Luo *The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Wenru ZengThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Xiaoqi ShaoThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Lun LiThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Qing WangThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Dongwei WangThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Yue ZhangThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Hongtao DiaoThe Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Xianglu RongGuangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou, 510006, China.
Yunlong BaiDepartment of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China. baiyunlong@ems.hrbmu.edu.cn.ORCID http://orcid.org/0000-0002-5095-3382
Jiao GuoGuangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou, 510006, China. gyguoyz@163.com.ORCID http://orcid.org/0000-0002-0050-5055
Guangdong Pharmaceutical University · CNGuangzhou University of Chinese Medicine · CNHarbin Medical University · CNMinistry of Education of the People's Republic of China · CN

Funding

Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) 2019B030302005Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2018YFC1704200National Natural Science Foundation of China (National Science Foundation of China) 81830113
6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) is a serious cardiac complication of diabetes that currently lacks specific treatment. The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has been suggested to contribute to the pathogenesis of cardiovascular diseases. However, whether cGAS-STING is involved in the development of DCM has not been established. Our study aimed to determine the role of cGAS-STING in the initiation of nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome-induced cardiac pyroptosis and chronic inflammation during the pathogenesis of DCM. C57BL/6J mice were preinjected with adeno-associated virus 9 (AAV9) intravenously via the tail vein to specifically knock down myocardial STING. After four weeks, mice with myocardium-specific knockdown of STING received injections of streptozotocin (STZ; 50 mg/kg) and a high-fat diet to induce diabetes. Measurements included echocardiography, immunohistochemical analyses, wheat germ agglutinin (WGA) staining, and western blotting. Here, we showed that the cGAS-STING signaling pathway was activated in diabetic hearts, which was indicated by the increased phosphorylation of TANK-binding kinase 1 (TBK1) and interferon (IFN) regulatory factor 3 (IRF3), leading to the activation of the NLRP3 inflammasome in the hearts of diabetic mice and proinflammatory cytokine release into serum. Moreover, STING knockdown via adeno-associated virus-9 (AAV9) in diabetic mouse heart alleviated cardiac pyroptosis and the inflammatory response, prevented diabetes-induced hypertrophy, and restored cardiac function. Mechanistically, we showed that palmitic acid (PA)-induced lipotoxicity impairs mitochondrial homeostasis, producing excessive mitochondrial reactive oxygen species (mtROS), which results in oxidative damage to mitochondrial DNA (mtDNA) and its release into the cytoplasm while switching on cGAS-STING-mediated pyroptosis in cardiomyocytes, thereby worsening the progression of diabetic cardiomyopathy. Our study demonstrated that activation of the cGAS-STING pathway caused by mitochondrial oxidative damage and mtDNA escape induced by free fatty acids promoted pyroptosis and proinflammatory responses in cardiomyocytes in a NLRP3 inflammasome-dependent manner, thus promoting myocardial hypertrophy during the progression of DCM.

Identifiers

PMID35538059
PMCPMC9091247
OpenAlexW4280512700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.